I've been practicing medicine at a renowned institution for 40 years. Society isn't ready for us to reverse the aging process across an entire population [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
agonists, so-called “weight loss drugs," captivated the world to such an extent that their primary manufacturers, Eli Lilly and Novo Nordisk , can't keep up with the demand for them. People who were morbidly obese or just slightly overweight suddenly saw the possibility that they could have the svelte body image they wanted. The market for these drugs is expected to reach $100 billion in 2030, after manufacturing finally catches up. Senator Bernie Sanders, no fan of pharmaceutical lobbyists, recently said that demand for these drugs could eventually bankrupt the Medicare program. If the scourge of obesity—which affects more than two in five adults in the U.S.—can be reversed so suddenly by a new development in medical science, it takes no great stretch of the imagination to contemplate the day when another ubiquitous “affliction” can be similarly addressed: aging. Already, research on the primary drivers of aging abounds. Stem cell and proteostatic dysfunction, telomere erosion, DNA
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- WeightWatchers CEO Sima Sistani is leaving the company [Yahoo! Finance]Yahoo! Finance
- PFE vs. NVO: Which Stock Is the Better Value Option? [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk's Wegovy-Fueled Gains Fading as Analyst Doubts Grow [Yahoo! Finance]Yahoo! Finance
- She took Ozempic, now she can't eat without vomiting. Lawsuit claims the drug made her ill [USA TODAY]USA TODAY
- Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 8/8/24 - Beat
NVO
Sec Filings
- 9/24/24 - Form 6-K
- 9/20/24 - Form 6-K
- 9/16/24 - Form 6-K
- NVO's page on the SEC website